Literature DB >> 16487816

Epistaxis: diagnosis and treatment.

Tate L Viehweg1, John B Roberson, J W Hudson.   

Abstract

Oral and maxillofacial surgeons are called on to evaluate and treat various emergencies, including acute epistaxis. Epistaxis is relatively benign in nature, but it can produce a serious, life-threatening situation. It has been estimated that up to 60% of the population has had at least 1 episode of epistaxis throughout their lifetime. Of this group, 6% seek medical care to treat epistaxis, with 1.6 in 10,000 requiring hospitalization. With fewer and fewer otorhinolaryngologists participating on hospital call schedules, it is critical for the oral and maxillofacial surgeon to be familiar with the anatomy, diagnosis, and treatment of acute epistaxis and associated medical concerns. Considerations concerning mechanism of injury, coagulopathies, and potential treatment options need to be assessed quickly and accurately to ensure the most appropriate treatment and positive outcome for the patient. The need to treat epistaxis in an emergent setting will often require the involvement of an oral and maxillofacial surgeon. By reviewing the anatomy, potential complications arising from associated medical conditions, and treatment options, patients can be accurately assessed and treated appropriately.

Entities:  

Mesh:

Year:  2006        PMID: 16487816     DOI: 10.1016/j.joms.2005.11.031

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  31 in total

1.  Severe spontaneous epistaxis: retrospective study in a tertiary ENT centre.

Authors:  Eline Marin; Jean-Baptiste Watelet; Philippe Gevaert; Thibaut Van Zele
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-19       Impact factor: 2.503

2.  Discomfort and costs in epistaxis treatment.

Authors:  Georgios Nikolaou; David Holzmann; Michael B Soyka
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-05       Impact factor: 2.503

3.  Evaluating the use of Floseal haemostatic matrix in the treatment of epistaxis: a prospective, control-matched longitudinal study.

Authors:  Andrew S Lau; Navdeep S Upile; Lepa Lazarova; Andrew C Swift
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-26       Impact factor: 2.503

4.  Septal branches of the anterior ethmoidal artery: anatomical considerations and clinical implications in the management of refractory epistaxis.

Authors:  Mario Turri-Zanoni; Alberto Daniele Arosio; Aldo Cassol Stamm; Paolo Battaglia; Giovanni Salzano; Antonio Romano; Paolo Castelnuovo; Frank Rikki Canevari
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-29       Impact factor: 2.503

5.  Acute Management of Massive Epistaxis After Nasotracheal Extubation.

Authors:  Kanta Kido; Yuki Shindo; Hitoshi Miyashita; Mikio Kusama; Shigekazu Sugino; Eiji Masaki
Journal:  Anesth Prog       Date:  2019

6.  Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis.

Authors:  Aysenur Meric Teker; Arzu Yasemin Korkut; Volkan Kahya; Orhan Gedikli
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-02-13       Impact factor: 2.503

7.  The Wexham Criteria: defining severe epistaxis to select patients requiring sphenopalatine artery ligation.

Authors:  Raj Lakhani; Irfan Syed; Ali Qureishi; Nigel Bleach
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-20       Impact factor: 2.503

8.  A change in UK epistaxis management.

Authors:  Tahwinder Upile; Waseem Jerjes; Fabian Sipaul; Mohammed El Maaytah; Sandeep Singh; Colin Hopper; Anthony Wright
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-04-08       Impact factor: 2.503

Review 9.  Current Approaches to Epistaxis Treatment in Primary and Secondary Care.

Authors:  Rafael Beck; Martin Sorge; Antonius Schneider; Andreas Dietz
Journal:  Dtsch Arztebl Int       Date:  2018-01-08       Impact factor: 5.594

10.  Quality of clinical aspects of call handling at Dutch out of hours centres: cross sectional national study.

Authors:  Hay P Derkx; Jan-Joost E Rethans; Arno M Muijtjens; Bas H Maiburg; Ron Winkens; Harrie G van Rooij; J André Knottnerus
Journal:  BMJ       Date:  2008-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.